Kavli Affiliate: Robert Rosner | Summary:Cancer and healthy cells have distinct distributions of molecular properties and thus respond differently to drugs. Cancer drugs ideally kill cancer cells while limiting harm to healthy cells. However, the inherent variance among cells in both cancer and healthy cell populations increases the difficulty of selective drug action. Here we […]
Continue.. Designing the statistically optimal drug for cancer therapy